XML 109 R78.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Capital Stock and Warrants (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Summary of Warrant Information

At September 30, 2019, outstanding warrants to purchase shares of common stock are as follows:

 

 

 

 

 

 

 

Shares Underlying

 

 

 

 

 

Outstanding

 

Exercise

 

Expiration

Warrants

    

Price

    

Date

2,980

 

$

1,505.00

 

March 16, 2020

2,246

 

$

567.00

 

March 31, 2021

597,881

 

$

21.00

 

May 10, 2022

1,249,955

 

$

5.60

 

October 16, 2023

1,200

 

$

1,680.00

 

None

1,854,262

 

 

  

 

  

 

 
AmpliPhi Biosciences Corporation [Member]    
Summary of Warrant Information  

At December 31, 2018, outstanding warrants to purchase shares of common stock, accounted for as equity or liabilities, are as follows:

 

 

 

 

 

 

Shares Underlying

    

 

 

    

 

Outstanding

 

Exercise

 

Expiration

Warrants

 

Price

 

Date

 

 

 

 

 

 

16,984

 

$

120.00

 

March 1, 2019

41,872

 

$

107.50

 

March 16, 2020

31,519

 

$

40.50

 

March 31, 2021

106,381

 

$

22.50

 

June 3, 2021

168,498

 

$

0.32

(1)  

November 22, 2021

7,920,933

 

$

1.50

 

May 10, 2022

17,500,000

 

$

0.40

 

October 15, 2023

1,175,000

(2)  

$

0.01

 

October 15, 2023

26,961,187

 

 

  

 

  


(1)

Exercise price of these warrants was reduced from $0.57 to $0.32 per share in connection with the October 2018 Financing. The exercise price of the warrants is subject to further adjustment upon future dilutive issuances of the Company’s common stock and stock combination events as defined in an exercise price adjustment provision in the warrant agreements.

(2)

In connection with the October 2018 Financing, the Company issued pre-funded warrants to purchase a total of 2,125,000 shares of the Company’s common stock for $0.01 a share, out of which 950,000 shares were exercised as of December 31, 2018, and warrants to purchase 1,175,000 shares of the Company’s common stock remained outstanding as of December 31, 2018.